What does APOTHEEK PRIKKEN do?

APOTHEEK PRIKKEN is a logistics company in Kapelle-op-den-Bos. Private Limited, started on 23 December 1985, 1 establishment.

What is the address of APOTHEEK PRIKKEN?

The registered office of APOTHEEK PRIKKEN is located at Londerzeelseweg 62, 1880 Kapelle-op-den-Bos.

Is APOTHEEK PRIKKEN still active?

Yes. According to the CBE (30 October 2026) APOTHEEK PRIKKEN is active, legal situation “Normale toestand”, started on 23 December 1985.

Is APOTHEEK PRIKKEN registered on Peppol?

Yes, APOTHEEK PRIKKEN is registered on the Peppol network with ID 0208:0428285385.

What is the enterprise number of APOTHEEK PRIKKEN?

The enterprise number of APOTHEEK PRIKKEN is BE0428285385.

When was APOTHEEK PRIKKEN founded?

APOTHEEK PRIKKEN was founded on 23 December 1985.

Who are the directors of APOTHEEK PRIKKEN?

According to the 2025 annual accounts, the directors of APOTHEEK PRIKKEN are: HSN BV.

Is APOTHEEK PRIKKEN a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 23 December 1985; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did APOTHEEK PRIKKEN make in 2025?

APOTHEEK PRIKKEN posted a profit after taxes of € 101,054 in financial year 2025.

What is the revenue of APOTHEEK PRIKKEN?

As a small company, APOTHEEK PRIKKEN is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 209,912.

How many employees does APOTHEEK PRIKKEN have?

According to the 2025 annual accounts, APOTHEEK PRIKKEN has 0.6 full-time equivalents (FTE).

APOTHEEK PRIKKEN (Private Limited) - Kapelle-op-den-Bos

Dossier APOTHEEK PRIKKEN, printed on 30 October 2026 from databakkes.be/en/0428285385/apotheek-prikken. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

APOTHEEK PRIKKEN from Kapelle-op-den-Bos, company number BE0428285385, closed financial year 2025 with a result of € 101,054 after tax. For that financial year APOTHEEK PRIKKEN recorded a gross margin of € 209,912 and equity of € 500,434. Compared with financial year 2024, the result moved from € 160,490 to € 101,054. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 23, 2026.

What it is worth Growing

€ 500,434

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 101,054

▼ 37% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 171,621

▲ 11% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 101,000 paid out

100 % of the profit went to the shareholders, mostly to HSN (100 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

0.6

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 37,557

▲ 4% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 5,190

▲ 73% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 7 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 406,934

▼ 8% vs 2024

€ 54,847 is repaid this year. At this pace the long-term loan is gone in ≈ 7 years.

Owed to suppliers

€ 127,845

▲ 20% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 11,594

▲ 2% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 208,361 Gross margin 2022: € 208,361 First fiscal year in the series	€ 214,227 Gross margin 2023: € 214,227 ▲ 3% vs 2022 (€ 208,361) Favourable step	€ 274,408 Gross margin 2024: € 274,408 ▲ 28% vs 2023 (€ 214,227) Favourable step	€ 209,912 Gross margin 2025: € 209,912 ▼ 24% vs 2024 (€ 274,408) Unfavourable step	▼ 24%
Profit after taxes	€ 90,668 Profit after taxes 2022: € 90,668 First fiscal year in the series	€ 127,252 Profit after taxes 2023: € 127,252 ▲ 40% vs 2022 (€ 90,668) Favourable step	€ 160,490 Profit after taxes 2024: € 160,490 ▲ 26% vs 2023 (€ 127,252) Favourable step	€ 101,054 Profit after taxes 2025: € 101,054 ▼ 37% vs 2024 (€ 160,490) Unfavourable step	▼ 37%
Equity	€ 500,238 Equity 2022: € 500,238 First fiscal year in the series	€ 500,290 Equity 2023: € 500,290 Unchanged (€ 500,238) Favourable step	€ 500,380 Equity 2024: € 500,380 Unchanged (€ 500,290) Favourable step	€ 500,434 Equity 2025: € 500,434 Unchanged (€ 500,380) Favourable step
Total debts	€ 982,130 Total debts 2022: € 982,130 First fiscal year in the series	€ 972,050 Total debts 2023: € 972,050 ▼ 1% vs 2022 (€ 982,130) Favourable step	€ 725,150 Total debts 2024: € 725,150 ▼ 25% vs 2023 (€ 972,050) Favourable step	€ 671,115 Total debts 2025: € 671,115 ▼ 7% vs 2024 (€ 725,150) Favourable step	▼ 7%
Cash	€ 289,068 Cash 2022: € 289,068 First fiscal year in the series	€ 313,422 Cash 2023: € 313,422 ▲ 8% vs 2022 (€ 289,068) Favourable step	€ 155,223 Cash 2024: € 155,223 ▼ 50% vs 2023 (€ 313,422) Unfavourable step	€ 171,621 Cash 2025: € 171,621 ▲ 11% vs 2024 (€ 155,223) Favourable step	▲ 11%
Land & buildings	€ 784,770 Land & buildings 2022: € 784,770 First fiscal year in the series	€ 758,757 Land & buildings 2023: € 758,757 ▼ 3% vs 2022 (€ 784,770) Unchanged	€ 734,091 Land & buildings 2024: € 734,091 ▼ 3% vs 2023 (€ 758,757) Unchanged	€ 712,562 Land & buildings 2025: € 712,562 ▼ 3% vs 2024 (€ 734,091) Unchanged	▼ 3%
Retained profit	€ 494,041 Retained profit 2022: € 494,041 First fiscal year in the series	€ 494,093 Retained profit 2023: € 494,093 Unchanged (€ 494,041) Favourable step	€ 494,183 Retained profit 2024: € 494,183 Unchanged (€ 494,093) Favourable step	€ 494,236 Retained profit 2025: € 494,236 Unchanged (€ 494,183) Favourable step
Dividend	€ 90,500 Dividend 2022: € 90,500 First fiscal year in the series	€ 127,200 Dividend 2023: € 127,200 ▲ 41% vs 2022 (€ 90,500) Unchanged	€ 160,400 Dividend 2024: € 160,400 ▲ 26% vs 2023 (€ 127,200) Unchanged	€ 101,000 Dividend 2025: € 101,000 ▼ 37% vs 2024 (€ 160,400) Unchanged	▼ 37%
Bank debt	€ 544,714 Bank debt 2022: € 544,714 First fiscal year in the series	€ 494,961 Bank debt 2023: € 494,961 ▼ 9% vs 2022 (€ 544,714) Favourable step	€ 443,609 Bank debt 2024: € 443,609 ▼ 10% vs 2023 (€ 494,961) Favourable step	€ 406,934 Bank debt 2025: € 406,934 ▼ 8% vs 2024 (€ 443,609) Favourable step	▼ 8%
Balance sheet total	€ 1,482,368 Balance sheet total 2022: € 1,482,368 First fiscal year in the series	€ 1,472,340 Balance sheet total 2023: € 1,472,340 ▼ 1% vs 2022 (€ 1,482,368) Unchanged	€ 1,225,531 Balance sheet total 2024: € 1,225,531 ▼ 17% vs 2023 (€ 1,472,340) Unchanged	€ 1,171,549 Balance sheet total 2025: € 1,171,549 ▼ 4% vs 2024 (€ 1,225,531) Unchanged	▼ 4%
Employees (FTE)	0.6 Employees (FTE) 2022: 0.6 First fiscal year in the series	0.6 Employees (FTE) 2023: 0.6 Unchanged (0.6) Unchanged	0.6 Employees (FTE) 2024: 0.6 Unchanged (0.6) Unchanged	0.6 Employees (FTE) 2025: 0.6 Unchanged (0.6) Unchanged

Key figures of APOTHEEK PRIKKEN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to APOTHEEK PRIKKEN?

What happened at APOTHEEK PRIKKEN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 23, 2026 New annual accounts for financial year 2025: profit of € 101,054 (▼ 37% vs 2024). Source: NBB ↗
Jan 1, 1986 New establishment in Kapelle-op-den-Bos. KBO
Dec 23, 1985 Start of the company according to the CBE. KBO

In short

From € 90,668 profit in 2022 to € 101,054 profit in 2025.

Paid € 53,732 in corporate taxes since 2022.

Best year ever: 2024, with € 160,490 profit.

Paid out € 479,100 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

HSN 100%

The stake of HSN comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

APOTHEEK PRIKKEN

Behind APOTHEEK PRIKKEN is HSN BV. The shares are held by HSN (100%).

Directors

According to the 2025 annual accounts

HSN BV

Director · represented by Steven Prikken

Shareholders

HSN

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Londerzeelseweg 62

1880 Kapelle-op-den-Bos

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

HSN same network

€ 159,255 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0428.285.385

VAT number

BE 0428.285.385

Registered office

Londerzeelseweg 62, 1880 Kapelle-op-den-Bos

Names & denominations

APOTHEEK PRIKKEN

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

23 December 1985

Peppol

Active · Active since 14 Oct 2025

Activities · NACE

Apothekers

Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗

APOTHEEK PRIKKEN

Financials

What happened to APOTHEEK PRIKKEN?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions